[Hospital financing in 2013: relevant changes for rheumatology].

[Hospital financing in 2015. Relevant changes for rheumatology]. Z Rheumatol (2015) 0.79

[Hospital financing in 2016 : Relevant changes for rheumatology]. Z Rheumatol (2016) 0.75

[Clinical pathways in rheumatological inpatient treatment - a structured process management]. Z Rheumatol (2007) 3.55

[Amendment of the structural quality for inpatient rheumatology. A forward-looking concept]. Z Rheumatol (2011) 1.74

[The G-DRG system 2008. Relevant changes for rheumatology]. Z Rheumatol (2008) 1.64

[Structural quality of rheumatology clinics for children and adolescents. Paper by a task force of the "Society of Pediatric and Adolescent Rheumatology" and of the "Association of Rheumatology Clinics in Germany"]. Z Rheumatol (2006) 1.27

[G-DRG system 2009: relevant changes for rheumatology]. Z Rheumatol (2009) 1.22

[The "outcome benchmarking in rheumatologic acute care" project of the Association of Rheumatologic Acute Care Clinics (VRA e.V.) in Germany]. Z Evid Fortbild Qual Gesundhwes (2011) 1.18

[Hospital financing for 2011: relevant changes in rheumatology]. Z Rheumatol (2011) 1.15

[Treat-to-target (T2T) from the perspective of inpatient rheumatology]. Z Rheumatol (2011) 1.01

[Hospital financing in 2012 - Relevant changes for rheumatology]. Z Rheumatol (2012) 1.00

[The G-DRG System 2009--relevant changes for rheumatology]. Z Rheumatol (2010) 0.99

Intermediary carbohydrate metabolism in embryonic life: Phosphorylation cycles. VI. Glucolysis without phosphorylation. VII. Experiments on the nature of non-phosphorylating glucolysis. Biochem J (1937) 7.09

Some factors influencing the formation of Robison ester from glycogen and inorganic phosphate in muscle extract. Biochem J (1939) 5.96

Molecular pathology of human haemoglobin. Nature (1968) 4.31

Clinical decision support systems for the practice of evidence-based medicine. J Am Med Inform Assoc (2001) 3.90

[Clinical pathways in rheumatological inpatient treatment - a structured process management]. Z Rheumatol (2007) 3.55

The effect of protein intake on the absorption of calcium and magnesium. Biochem J (1942) 3.02

Studies on iron in plants with special observations on the chlorophyll: iron ratio. Biochem J (1941) 2.83

[Increasingly appropriate depiction of rheumatology for G-DRG reimbursement 2006]. Z Rheumatol (2006) 2.81

[Clinical pathways: effective and efficient inpatient treatment]. Chirurg (2003) 2.71

[Rheumatologic treatment in the G-DRG system]. Z Rheumatol (2004) 2.58

Post-Traumatic Confusional State Treated with Massive Doses of Nicotinic Acid. Can Med Assoc J (1944) 2.54

[The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives]. Z Rheumatol (2005) 2.31

Haemoglobin G Copenhagen and haemoglobin J Cambridge. Two new beta-chain variants of haemoglobin A. Biochim Biophys Acta (1967) 2.26

Intermediary carbohydrate metabolism in embryonic life: Glyceraldehyde and glucolysis. Biochem J (1937) 2.15

Sickling tests. Pitfalls in performance and interpretation. JAMA (1967) 2.13

Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet (1986) 2.12

Variations in the structure of human haemoglobin. With particular reference to the unstable haemoglobins. Br Med Bull (1969) 2.07

Haemoglobin gene frequencies in the Jamaican population: a study in 100,000 newborns. Br J Haematol (1986) 2.00

Cation antagonism in blood coagulation. J Physiol (1944) 1.95

A distant gene deletion affects beta-globin gene function in an atypical gamma delta beta-thalassemia. J Clin Invest (1985) 1.85

Molecular evolution of myoglobin and the fossil record: a phylogenetic synthesis. Nature (1973) 1.76

Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes. Lancet (1977) 1.76

[The G-DRG system 2008. Relevant changes for rheumatology]. Z Rheumatol (2008) 1.64

Haemoglobin Hammersmith (beta-42 (CDI) Phe replaced by ser). Nature (1967) 1.52

[Changes for rheumatology in the G-DRG system 2005]. Z Rheumatol (2005) 1.45

Abnormal haem binding and globin SH group blockade in unstable haemoglobins. Nature (1968) 1.44

Moleuclar pathology of human haemoglobin: stereochemical interpretation of abnormal oxygen affinities. Nature (1971) 1.40

A new hemoglobin variant resembling hemoglobin E. Hemoglobin E Saskatoon: beta-22 Glu replaced by Lys. Can J Biochem (1967) 1.40

[Rheumatology coding guideline. A guideline for clinical practice]. Z Rheumatol (2002) 1.40

[Classification of severely injured patients in the G-DRG System 2008]. Unfallchirurg (2009) 1.38

Human cholinesterase (pseudocholinesterase): genetic variants and their recognition. Br J Anaesth (1969) 1.35

Haemoglobin Köln (beta-98 valine--methionine): an unstable protein causing inclusion-body anaemia. Nature (1966) 1.33

[What changes for rheumatologists in the G-DRG system 2006?]. Z Rheumatol (2006) 1.33

Differences between alpha- and beta-chain mutants of human haemoglobin and between alpha- and beta-thalassaemia. Possible duplication of the alpha-chain gene. Br Med J (1968) 1.33

Two haemoglobins Q, alpha-74 (EF3) and alpha-75 (EF4) aspartic acid to histidine. Br J Haematol (1970) 1.28

The unstable haemoglobin haemolytic anaemias. Semin Hematol (1969) 1.27

[Structural quality of rheumatology clinics for children and adolescents. Paper by a task force of the "Society of Pediatric and Adolescent Rheumatology" and of the "Association of Rheumatology Clinics in Germany"]. Z Rheumatol (2006) 1.27

Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clin Exp Allergy (2006) 1.23

Haemoglobin O in An Arab Family. Br Med J (1960) 1.23

[G-DRG system 2009: relevant changes for rheumatology]. Z Rheumatol (2009) 1.22

Haemoglobin Tak: a variant with additional residues at the end of the beta-chains. Lancet (1971) 1.20

Evaluation of the effects of probiotic supplementation from the neonatal period on innate immune development in infancy. Clin Exp Allergy (2006) 1.20

[Hospital financing for 2011: relevant changes in rheumatology]. Z Rheumatol (2011) 1.15

[Adjustment of the German DRG system in 2009]. Urologe A (2009) 1.15

Serum-pseudocholinesterase in depression with notable anxiety. Lancet (1965) 1.12

Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra. J Neurosci Res (1998) 1.11

Different types of alpha-thalassaemia and significance of haemoglobin Bart's in neonates. Lancet (1970) 1.10

A Ghanaian adult, homozygous for hereditary persistence of foetal haemoglobin and heterozygous for elliptocytosis. Acta Haematol (1970) 1.10

The antibody response to myoglobin is independent of the immunized species. Analysis in terms of replacements in the antigenic sites and in environmental residues of the cross-reactions of fifteen myoglobins with sperm-whale myoglobin antisera raised in different species. Biochem J (1980) 1.10

On the evolution of myoglobin. Philos Trans R Soc Lond B Biol Sci (1978) 1.09

Abnormal haemoglobins and the genetic code. Nature (1965) 1.08

PRE3, highly homologous to the human major histocompatibility complex-linked LMP2 (RING12) gene, codes for a yeast proteasome subunit necessary for the peptidylglutamyl-peptide hydrolyzing activity. FEBS Lett (1994) 1.06

Draft guideline on detection of toxicity to reproduction for medicinal products. Adverse Drug React Toxicol Rev (1991) 1.06

[Appropriate representation of rheumatology in the G-DRG system]. Z Rheumatol (2004) 1.05

Ultrastructural findings in soft tissues adjacent to titanium plates used in jaw fracture treatment. Int J Oral Maxillofac Surg (1993) 1.05

Autoantibodies to cartilage collagens in relapsing polychondritis. Arch Dermatol Res (1993) 1.05

Haemoglobin Q India (alpha 64(E13) aspartic acid histidine) associated with beta-thalassemia observed in three Sindhi families. J Med Genet (1972) 1.05

Hereditary non-spherocytic haemolytic anaemia with post-splenectomy inclusion bodies and pigmenturia caused by an unstable haemoglobin Santa Ana-beta-88 (F4) leucine--proline. J Med Genet (1968) 1.04

Hemoglobin J Cape Town-alpha-2 92 arginine replaced by glutamine beta-2. Nature (1966) 1.04

The accuracy of haemoglobin determination by the copper sulphate-blood gravity method in indian soldiers. J Physiol (1946) 1.04

Hemoglobin Duarte: (alpha2beta2 62(E6)Ala leads to Pro): a new unstable hemoglobin with increased oxygen affinity. Blood (1974) 1.03

Haemoglobin Korle-Bu (beta 73 aspartic acid replaced by asparagine) showing one of the two amino acid substitutions of haemoglobin C Harlem. J Med Genet (1968) 1.03

The influence of steric and electronic parameters on the substrate behavior of -oxo acids to yeast pyruvate decarboxylase. Eur J Biochem (1973) 1.03

Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies. Arch Toxicol (1986) 1.02

[Possibilities and limitations for the representation of ENT medicine in the G-DRG reimbursement system. Results of the DRG evaluation project]. HNO (2006) 1.01

Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis. Am J Kidney Dis (1999) 1.00

Mycoplasma crocodyli sp. nov., a new species from crocodiles. Int J Syst Bacteriol (1997) 1.00

Emergency coronary artery bypass grafting after failed coronary angioplasty: what has changed in a decade? Ann Thorac Surg (2000) 1.00

[Hospital financing in 2012 - Relevant changes for rheumatology]. Z Rheumatol (2012) 1.00

[The G-DRG System 2009--relevant changes for rheumatology]. Z Rheumatol (2010) 0.99